Surgical management of pleomorphic adenoma of the salivary glands: our experience

被引:0
作者
Ascani, G. [1 ]
Messi, M. [1 ]
Balercia, P. [1 ]
机构
[1] Univ Osped Riuniti, Unita Operativa Chirurg Maxillo Facciale, Azienda Osped, Ancona, Italy
来源
GIORNALE DI CHIRURGIA | 2008年 / 29卷 / 8-9期
关键词
Pleomorphic adenoma; Salivary glands; Enucleation; Parotid neoplasms;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Pleomorphic adenoma is a benign epithelial tumour of adenoid structure preferentially arising from the parotid gland. Aim. To analyse the outcome of patients with pleomorphic adenoma from salivary glands in order to evaluate the surgical strategy. Patients and methods. This is an audit of a 15-year period where 347 pleomorphic adenomas of the salivary glands were treated by the authors. Data was collected and reviewed from the records of all the patients in order to analyze gender, age, site, operative procedure, postoperative complications and recurrences. Results. The pleomorphic adenoma preferentially originated in the parotid gland (89,1%), and rarely in other glands. The tumour occurred more often in females than in males (F: M = 1,5). Average age was 43,43 years. Pericapsular enucleation of parotid neoplasms was the commonest operation performed. Other procedures were: superficial parotidectomy, total conservative parotidectomy, submandibular total sialoadenectomy and radical surgery for lesions of the palate. Postoperative complication was temporary facial weakness in 18 patients; 2 patients developed the Frey's syndrome. No recurrences were developed in follow-up period (25-177 months). Conclusion. The epidemiological aspects of pleomorphic adenoma of salivary glands retrieved in our study are similar to those reported in literature; moreover this study demonstrates that pericapsular enucleation is a viable alternative to superficial parotidectomy for the majority of parotid localizations, associated with reduced morbidity without oncological compromise.
引用
收藏
页码:343 / 346
页数:4
相关论文
共 20 条
[1]  
Ascani G, 2006, Minerva Stomatol, V55, P209
[2]  
Bradley Patrick J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P69, DOI 10.1097/00020840-200404000-00002
[3]  
Carlson E R, 1998, Atlas Oral Maxillofac Surg Clin North Am, V6, P75
[4]  
Ellis GL, 1991, SURG PATHOLOGY SALIV
[5]  
Hancock BD, 1999, ANN ROY COLL SURG, V81, P299
[6]  
Hee CGQ, 2001, AUST NZ J SURG, V71, P345, DOI 10.1046/j.1440-1622.2001.02121.x
[7]   BENIGN PAROTID ADENOMAS - A REVIEW OF THE PRINCESS-MARGARET-HOSPITAL EXPERIENCE [J].
LIU, FF ;
ROTSTEIN, L ;
DAVISON, AJ ;
PINTILIE, M ;
OSULLIVAN, B ;
PAYNE, DG ;
WARDE, P ;
CUMMINGS, B .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (03) :177-183
[8]   Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise [J].
McGurk, M ;
Thomas, BL ;
Renehan, AG .
BRITISH JOURNAL OF CANCER, 2003, 89 (09) :1610-1613
[9]  
Nardone M, 2002, Acta Otorhinolaryngol Ital, V22, P158
[10]   RELATIONSHIP OF INTRAOPERATIVE RUPTURE OF PLEOMORPHIC ADENOMAS TO RECURRENCE - AN 11-25 YEAR FOLLOW-UP-STUDY [J].
NATVIG, K ;
SOBERG, R .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1994, 16 (03) :213-217